ARK Genomic Revolution ETF vs DENTSPLY SIRONA Inc — how do they compare? ARK Genomic Revolution ETF trades at $44.5, while DENTSPLY SIRONA Inc trades at $11.69 (market cap $2.31B). The key difference: DENTSPLY SIRONA Inc pays a 5.04% dividend while ARK Genomic Revolution ETF pays none, and ARK Genomic Revolution ETF is trading nearer its 52-week high, DENTSPLY SIRONA Inc nearer its low. Which is the better fit depends on your goals.
| ARKG | XRAY | |
|---|---|---|
Sector | Sector/Thematic | Health |
52-Week High | $44.55 | $14.68 |
52-Week Low | $24.02 | $9.64 |
Market Cap | — | $2.31B |
Enterprise Value | — | $4.39B |
Dividend Yield | — | 5.04% |
Trailing returns across standard periods
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →Dentsply Sirona Inc is a global manufacturer and distributor of dental supplies and equipment. The company's operating segments include Technologies & Equipment, which is responsible for the design, manufacture, sales, and distribution of products including dental implants, CAD/CAM systems, orthodontic clear aligner products, imaging systems, treatment centers, instruments, as well as certain healthcare device products, primarily catheters
Read more on XRAY →